Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal. Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions,...
ANI Pharmaceuticals’ Acquisition of Alimera Sciences
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...